8-C-Glucosyl-(2\'-O-cinnamoyl)-7-O-methylaloediol A



Compound IDCDAMM01326
Common name8-C-Glucosyl-(2\'-O-cinnamoyl)-7-O-methylaloediol A
IUPAC name[2-[2-(1,2-dihydroxypropyl)-7-methoxy-5-methyl-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 3-phenylprop-2-enoate
Molecular formulaC29H32O11

Experimental data

Retention time0.47
Adduct[2M+K]+
Actual mz1151.36
Theoretical mz1151.35
Error9.42
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.7356

Identifiers and class information

Inchi keyHLFYJFSIVFUDFJ-MBYLOJIJNA-N
SmilesO=C(OC1C(O)C(O)C(OC1C2=C(OC)C=C(C=3C(=O)C=C(OC32)C(O)C(O)C)C)CO)C=CC=4C=CC=CC4
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)13
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)556.565
Computed dipole moment(dipole)3.935
Total solvent accessible surface area (SASA)840.521
Hydrophobic component of SASA (FOSA)328.322
Hydrophilic component of SASA (FISA)245.953
Pie component of the SASA (PISA)266.246
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1613.97
Number of hydrogen bond donors (donorHB)5
Number of hydrogen bond acceptors (accptHB)15.45
Free energy of solvation of dipole (dip^2/V)0.0095917
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0411022
Globularity descriptor (glob)0.791675
Predicted polarizability in cubic angstroms (QPpolrz)52.632
Predicted hexadecane/gas partition coefficient (QPlogPC16)17.979
Predicted octanol/gas partition coefficient (QPlogPoct)33.684
Predicted water/gas partition coefficient (QPlogPw)24.899
Predicted octanol/water partition coefficient (QPlogPo/w)1.234
Predicted aqueous solubility (QPlogS)-4.04
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.214
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.173
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)46.082
Predicted brain/blood partition coefficient (QPlogBB)-2.836
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)17.774
Predicted skin permeability, log Kp (QPlogKp)-3.866
PM3 calculated ionization potential (IP(ev))9.508
PM3 calculated electron affinity (EA(eV))0.814
Number of likely metabolic reactions (#metab)9
Prediction of binding to human serum albumin (QPlogKhsa)-0.523
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)38.027
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)172.735
Number of nitrogen and oxygen atoms (#NandO)11
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P14151SELLLeukocyte adhesion molecule-1T60526SEA
P09382LGALS1Galectin-1T09544SEA
P05231IL6Interleukin-6T32578SEA
Q15717ELAVL1ELAV-like protein 1T78349SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T60526DI0037Asthma[ICD-11: CA23]P14151SELL
T60526DI0088Circulatory system disease[ICD-11: BE2Z]P14151SELL
T32578DI0028Anemia[ICD-11: 3A00-3A9Z]P05231IL6

Copyright © 2025